Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canosa

Showing results (521-530 of 638) with videos related to

Pageof 64
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Journal of Neurology|November 2, 2022
Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[<sup>18</sup>F]FDG-PET studyAntonio Canosa, Alessio Martino, Alessandro Giuliani, et al.
Journal of Cardiac Surgery|November 20, 2022
Brain and lower body protection during aortic arch surgeryAntonio M Calafiore, Ruggero de Paulis, Severino Iesu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Oncotarget|February 13, 2016
Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cellsHagen Kulbe, Francesco Iorio, Probir Chakravarty, et al.
Neurobiology of Aging|February 27, 2021
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairmentPaola Lanteri, Irene Meola, Antonio Canosa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 11, 2022
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patientsRosario Vasta, Stefano Callegaro, Maurizio Grassano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2016
GIV/Girdin activates Gαi and inhibits Gαs via the same motifVijay Gupta, Deepali Bhandari, Anthony Leyme, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 27, 2022
Systematic evaluation of genetic mutations in ALS: a population-based studyMaurizio Grassano, Andrea Calvo, Cristina Moglia, et al.
Pageof 64

Showing results (521-530 of 638) with videos related to

Sort By:
Pageof 64
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Journal of Neurology|November 2, 2022
Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[<sup>18</sup>F]FDG-PET studyAntonio Canosa, Alessio Martino, Alessandro Giuliani, et al.
Journal of Cardiac Surgery|November 20, 2022
Brain and lower body protection during aortic arch surgeryAntonio M Calafiore, Ruggero de Paulis, Severino Iesu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Oncotarget|February 13, 2016
Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cellsHagen Kulbe, Francesco Iorio, Probir Chakravarty, et al.
Neurobiology of Aging|February 27, 2021
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairmentPaola Lanteri, Irene Meola, Antonio Canosa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 11, 2022
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patientsRosario Vasta, Stefano Callegaro, Maurizio Grassano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2016
GIV/Girdin activates Gαi and inhibits Gαs via the same motifVijay Gupta, Deepali Bhandari, Anthony Leyme, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 27, 2022
Systematic evaluation of genetic mutations in ALS: a population-based studyMaurizio Grassano, Andrea Calvo, Cristina Moglia, et al.
Pageof 64